ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,086Medicare Part D Prescriptions Filled, Including Refills

Rank: 191 out of 890

$665K Total Retail Price of All Prescriptions

Rank: 158 out of 890

443 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 462 392 1 2
LISINOPRIL 341 276 2 4
METOPROLOL TARTRATE 336 269 3 15
FUROSEMIDE 320 294 4 7
AMLODIPINE BESYLATE 314 252 5 1
SIMVASTATIN 263 228 6 5
HYDROCODONE-ACETAMINOPHEN 251 191 S3 7 3
NAMENDA 232 232 8 36
GABAPENTIN 217 151 9 12
METFORMIN HCL 197 145 10 6
LANTUS 183 157 11 50
POTASSIUM CHLORIDE 140 129 12 11
DONEPEZIL HCL 137 137 13 30
PREDNISONE 131 122 14 47
PRAVASTATIN SODIUM 125 106 15 10
CITALOPRAM HBR 124 101 16 20
OMEPRAZOLE 119 76 17 8
TRAMADOL HCL 108 59 18 16
SERTRALINE HCL 106 95 19 26
KLOR-CON M20 105 92 20 72
CARVEDILOL 103 88 21 22
FAMOTIDINE 101 93 22 90
CLOPIDOGREL 96 80 23 28
HYDROCHLOROTHIAZIDE 90 59 24 9
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 69 25 76
ADVAIR DISKUS 89 74 25 52
TAMSULOSIN HCL 88 80 27 32
NEXIUM 87 54 28 14
AMITRIPTYLINE HCL 86 75 R 29 43
ATORVASTATIN CALCIUM 85 69 30 13
TRAZODONE HCL 84 64 31 40
PLAVIX 80 75 32 42
PANTOPRAZOLE SODIUM 79 67 33 34
CYMBALTA 75 42 34 45
TRIAMTERENE-HCTZ 75 66 34 61
RANITIDINE HCL 75 59 34 49
RISPERIDONE 74 66 37 78
MIRTAZAPINE 73 70 38 82
METOPROLOL SUCCINATE 72 57 39 17
CARBIDOPA-LEVODOPA 72 71 39 136
MELOXICAM 71 58 41 18
ALLOPURINOL 71 71 41 31
POLYETHYLENE GLYCOL 3350 69 68 43 67
NOVOLIN R 69 65 43 153
CIPROFLOXACIN HCL 68 54 45 58
GLIMEPIRIDE 67 51 46 27
ZOLPIDEM TARTRATE 66 47 47 19
SINGULAIR 66 52 47 79
ALBUTEROL SULFATE 66 65 47 162
CLONIDINE HCL 63 35 50 35
HUMALOG 63 53 50 214
ATENOLOL 63 57 50 23
SPIRIVA 62 36 53 66
AZITHROMYCIN 60 41 54 37
PROAIR HFA 59 42 55 55
MEGESTROL ACETATE 58 57 R 56 92
OLANZAPINE 55 52 57 145
KLOR-CON M10 54 52 58 165
LEVOFLOXACIN 53 44 59 107
LOSARTAN-HYDROCHLOROTHIAZIDE 52 48 60 57
PROMETHAZINE HCL 51 21 R 61 104
VESICARE 51 37 61 188
METOCLOPRAMIDE HCL 51 14 61 125
GLYBURIDE 50 50 R 64 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.